Thermo Fisher Scientific Completes Tender Offer for Dionex Corporation

Thermo Fisher Scientific TMO today announced that it has successfully completed its tender offer for Dionex Corporation DNEX, which expired at 7:00 pm, New York City time, on Friday, May 13, 2011. Based on preliminary information from the depositary for the tender, as of the expiration of the tender offer approximately 16,304,830 shares were validly tendered and not withdrawn in the tender offer, representing approximately 93% of Dionex's issued and outstanding shares. All validly tendered shares have been accepted for payment, which will be made in accordance with the terms of the tender offer. Thermo Fisher intends to complete its acquisition of the remaining shares of Dionex through a short-form merger later this week. In the short-form merger, any remaining Dionex shares will be exchanged for $118.50 per share in cash.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsM&AHealth CareLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!